I recently had the good fortune to speak briefly with Pamela Ritchie of Bloomberg TV Canada about prescription drug pricing. My message? The US approach works when three features are in place:
- A robust regulatory pathway that allows clinically comparable products and services to go head to head in the marketplace.
- A pharmacy benefits management company focused on pitting entities in the supply chain (ideally one built on a business model of alignment).
- A deep, practical understanding of human behavior necessary to ensure that patients move from one drug to another, or one pharmacy to another.
You can watch me make my case (and hawk my book a bit) on Bloomberg TV Canada – about 1 minute into the video.
